Interview with David F. Penson, MD.
Small study demonstrates the promise of PET-CT using a radiotracer that targets the prostate-specific membrane antigen.
No residual tumor was found in 5.4% of men who received androgen deprivation therapy prior to radical surgery for high-risk prostate cancer.
Men receiving active surveillance were 24 times more likely to die from causes other than prostate cancer over 15 years.
Association found in patients with lymph node involvement.
Giving docetaxel before abiraterone does not improve progression-free and overall survival compared with the reverse sequence.
Men with PCa have a 4-fold increased risk of suicidal death within 3 months of diagnosis compared to men who have other solid cancers.
This laboratory measure could be useful in treatment decision algorithms.
The technique, with cognitive assistance, identified recurrent tumors in 80% of patients.
PNI in prostate biopsy specimens are associated with an 11-fold increased risk of bone metastasis.
Acupuncture's ability to stimulate endorphin production may partly explain the clinical improvements.
It more accurately predicted the actual clinical risk category at final pathology compared with transrectal ultrasonography-guided biopsy.
A set of genes may identify a prostate cancer subtype in African American patients that needs aggressive treatment.
Surgery for prostate cancer may affect relationship satisfaction among couples, which may ultimately disrupt recovery.
The biochemical recurrence rate after radical prostatectomy is similar to that associated with positive surgical margins.
Compared with laparoscopic radical prostatectomy, robotic-assisted laparoscopic prostatectomy is associated with a 51% increased likelihood of return of erectile function.
Adding chemotherapy to hormone therapy added 14 months to patients' lives in study.
New data suggest a prognosis role for the neutrophil to lymphocyte ratio.
In a study, only older age and greater total PSA density were independently associated with an increased risk of a PCa diagnosis.
Older adults react differently to treatment, oncology group notes.
Patients with longer life expectancy are most at risk of cardiac morbidity, researchers concluded.
Hypogonadal men are more likely than those with normal testosterone to have prostate biopsy results showing high-grade PCa.
Quality studies are still needed to answer crucial questions about TRT and prostate cancer, cardiovascular risk.
Almost 1 in 3 not told cancer treatment might affect future fertility.
Study in England shows that that 1 in 12 black men die from the malignancy compared with 1 in 24 white men.
Results of a prospective study have implications for patient counseling.
No improvement in quality of life, even for patients with good baseline performance status.
The biomarkers PHI and PCA3 demonstrated high diagnostic accuracy in discriminating prostate cancer from prostatitis in re-biopsy candidates.
Statin use following diagnosis of localized PCa does not significantly reduce the risk of metastasis or death from PCa.
The finding is based on a study of men who underwent radical surgery for pT3aN0/NxR1 tumors but received no adjuvant or neoadjuvant therapy.
- Few African American and Latinos Pursuing Careers as Physicians
- Recent Developments in Prostate Cancer Management
- Novel Technique May Improve Detection of Aggressive Prostate Cancer
- Abnormal Mineral, Bone Markers in Dialysis Patients Hike Mortality
- Longer Dialysis Session Gap Raises Hospitalization, Death Risk
Sign Up for Free e-newsletters
NEPHROLOGY & UROLOGY NEWS
- Acute Kidney Injury (AKI)
- Chronic Kidney Disease (CKD)
- Contrast Nephropathy
- Cardiovascular Disease (CVD)
- Diabetic Nephropathy
- End-stage Renal Disease (ESRD)
- Lupus Nephritis
- Peritoneal Dialysis
- Secondary Hyperparathyroidism (SHPT)